Putnam Investments’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-106,493
Closed -$1.12M 1259
2016
Q3
$1.12M Sell
106,493
-69,236
-39% -$995K ﹤0.01% 997
2016
Q2
$2.56M Buy
175,729
+61,573
+54% +$1.05M 0.01% 852
2016
Q1
$2.2M Buy
114,156
+2,391
+2% +$48.3K 0.01% 925
2015
Q4
$2.7M Sell
111,765
-2,192
-2% -$54.9K 0.01% 891
2015
Q3
$2.8M Buy
113,957
+3,221
+3% +$91.2K 0.01% 890
2015
Q2
$2.59M Sell
110,736
-492,336
-82% -$10.7M 0.01% 975
2015
Q1
$13.5M Sell
603,072
-825,020
-58% -$15.8M 0.03% 426
2014
Q4
$24.1M Buy
1,428,092
+713,098
+100% +$10.9M 0.05% 312
2014
Q3
$10.2M Buy
714,994
+70,057
+11% +$1.01M 0.02% 476
2014
Q2
$10.3M Buy
644,937
+66,913
+12% +$1.01M 0.02% 475
2014
Q1
$10.4M Buy
+578,024
New +$10.7M 0.02% 460

Other funds holding DVAX

Putnam Investments's DVAX Position: Q4 2016 in Review

Putnam Investments sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 106,493 shares — an estimated $1.12M sold.

Putnam Investments first reported a position in DVAX in Q1 2014 and held it in 11 quarters. The position peaked at $24.1M in Q4 2014. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

  • Putnam Investments reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 106,493 Dynavax Technologies shares in Q4 2016, an estimated $1.12M.
  • Putnam Investments first reported a position in Dynavax Technologies in Q1 2014 and held it in 11 quarters.
  • Putnam Investments's Dynavax Technologies position peaked at $24.1M in Q4 2014.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.